Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071006
Status:
COMPLETED
Last Update Posted:
2012-06-08
First Post:
2003-10-09
Brief Title:
AG-013736 Axitinib In Patients With Poor Prognosis Acute Myeloid Leukemia AML Or Myelodysplastic Syndrome MDS
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-07
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-09
First Submit QC Date:
October 10 2003
Study First Post Date:
2003-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-03-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-31
Last Update Post Date:
2012-06-08
Last Update Post Date Type:
ESTIMATED